Wells Fargo
QNTM

Wells Fargo’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Wells Fargo’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$477 Buy
+100
New +$451 ﹤0.01% 6399

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wells Fargo's QNTM Position: Q1 2026 in Review

Wells Fargo opened a new position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2026: 100 shares worth $477. The stake represents ﹤0.01% of the portfolio and ranks #6399 among its holdings.

25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Wells Fargo held 100 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $477 as of Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares was a new Wells Fargo position in Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6399 holding.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.